Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.49 CAD | 0.00% | +3.47% | -16.76% |
Apr. 11 | Oncolytics Biotech Inc. Announces the Submission of a Type C Meeting Request to the FDA | CI |
Apr. 11 | Oncolytics Biotech Down 1.8% In US Premarket As Submits Type C Meeting Request to FDA | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.76% | 82.03M | |
+1.94% | 42.59B | |
+8.27% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.94% | 24.81B | |
-24.46% | 18.17B | |
+28.71% | 12.05B | |
-2.87% | 11.7B | |
+6.83% | 11.1B |
- Stock Market
- Equities
- ONC Stock
- News Oncolytics Biotech Inc.
- Oncolytics Biotech Announces Presentations at Upcoming San Antonio Breast Cancer Symposium